Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$6.08 - $10.44 $80,146 - $137,620
-13,182 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$7.14 - $14.41 $75,576 - $152,529
10,585 Added 407.59%
13,182 $94,000
Q1 2020

May 13, 2020

BUY
$5.89 - $17.67 $176 - $530
30 Added 1.17%
2,597 $25,000
Q4 2019

Feb 14, 2020

BUY
$9.13 - $13.9 $23,436 - $35,681
2,567 New
2,567 $34,000

Others Institutions Holding GRTX

About Galera Therapeutics, Inc.


  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $3.76M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.